Chemotherapy Flashcards

1
Q

What are the main considerations for keeping people safe?

A
Designated area, limited access and no throughway
Keep cytotoxic drugs stored separately
Trained and knowledgeable staff only 
No eating/ drinking/ cosmetics
Minimise exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do you dose chemo agents?

A

Dosing
• mg/m2 if over 10 kg
• Often mg/kg if under 10 kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you prepare to give chemo?

A

• Work in a calm environment, sedate the patient if
necessary
• Indwelling intravenous catheter
• Perfectly placed at first attempt
• Flush catheter to check patency with saline, continue
to check catheter placement throughout
• Check dose of drug is correct!
• Inject via a luer lock bung / screw infusion set / closed system
• Do not obscure catheter and vein during administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do deal with the possibility of extravasion?

A

• Warn clients of risks and worse case scenario outcomes.
• Consider sedation of all patients having vesicant drugs particularly infusions.
• Always use an IV catheter placed perfectly at the first
attempt.
• Check catheter patency, postioning regularly and closely supervisor patients being treated.
• Recorded which veins have been used.
• Know how to deal with the consequences of
extravasations and seek advice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you give IV boluses?

A
Drugs given as boluses
• Vincristine
• Vinblastine
• Cyclophosphamide
• Actinomycin-D
• Methotrexate
Proceedure
• Place catheter
• Check patency and flush
• Administer drug whilst checking patency
• Flush (do not draw back)
• Remove catheter
• Place bandage over site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you give infusions?

A

Sedate patient if necessary.
Place catheter
Check patency and flush
Administer drug by slow infusion
A. 15 - 20 mins for epirubicin and doxorubicin
B. 5 – 10 mins for carboplatin, mitoxantrone
Monitor patient and catheter the whole time.
Flush line and catheter (do not draw back)
Remove catheter
Place bandage over site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you give tabletted meds?

A
•Tabletted drugs include:
Chlorambucil
Cyclophosphamide
Melphalan
Lomustine
•Proceedure
Prepare drugs on an absorbent pad
Never crush or break (compound if necessary)
Wear waterproof gloves e.g.
Nitrile or vinyl
Wash after treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you deal with waste disposal?

A

1.Special bins for all equipment used to administer cytotoxics.
2.Waste from patients needs to be doubled bagged and marked as contaminated.
3.Waste needs to be kept in a dedicated area for cytotoxic waste
•Arrangement for appropriate disposal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How frequent are s/e from chemotherapy

A

Around 30 % have some degree of side effect at some stage during treatment
Only 5 % hospitalised
Mortality rate less than 1 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How long are patients sick for if they do get sick?

A

GI side effects usually seen in the first 4 days and resolve in the same time period
Bone marrow suppression usually from 7 days and resolved by 10 days
The rest of the time patients are well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which breeds are well known to be more sensitive to anthracyclines & vinca alkaloids

A

Various collies
Poss westies
Australian Shepherds
Long haired whippets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If there is a hepatopathy, which drugs need to have their dose re-considered?

A

anthracyclines
Cyclophosphamide
vinca alkaloids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If there is renal disease, which drugs need to have their dose re-considered?

A

Cyclophosphamide
Methotrexate
Carboplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the most common general chemo s/e?

A
  • Bone marrow suppression
  • Gastrointestinal
  • Alopecia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does bone marrow suppression d/t chemotherapy present?

A

• Can see low:
1. Platelet counts (thrombocytopaenia)
2. Neutrophil (neutropenia)
3. None – regenerative anaemia
• Counts are usually lowest after 7 days (Nadir)
• Usually return to normal 3 – 4 days after this
• Some drugs can cause prolonged or permanent
problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which drugs are the most myelosuppressive

A
Anthracyclines
Cyclophosphamide
Lomustine
Carboplatin
l-asparaginase and vincristine together
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which drugs are moderately myelosuppressive?

A

Cytosine Arabinoside
Methotrexate
Melphalan
Vinblastine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which drugs are mildly myelosuppressive?

A

Vincristine

Chlorambucil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What should you do if a patient in neutropaenic

A

Counts above 1 x 109/l
• Patients are unlikely to be at an increased risk of sepsis
Monitor patient closely

Patients which are well with counts below 1 x 10 /l 9
• Patients at an increased risk of sepsis
Manage as outpatient
Keep away from potentially infectious animals
Owner to check temperature twice daily
Anaerobe sparing antibiotics

Patients which are sick with counts below 1 x 109/l
• Patient may be septic
Admit, barrier nurse
IV fluids
CBC and biochemistry to assess patient status
Broad spectrum antibiotics
If there is no rapid improvement look for focus of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How does alopecia occur in chemo?

A

Rare to see a significant change
May see it in constantly growing hair breeds
May lose guard hairs and whiskers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Outline gastrointestinal side effects

A

• Can see vomiting, diarrhoea and anorexia
Usually seen within the 2 – 5 days of chemo.
• Due to drugs causing:
1. Nausea – In the first 12 hours after treatment
2. Damage to enterocytes – After 12 hours
• Clinical signs:
Self limiting
Usually resolve spontaneously within 2 – 3 days

22
Q

Which drugs commonly cause GI signs?

A

Anthracyclines

Methotrexate

23
Q

Which drugs occasionally cause GI signs?

A
Mitoxantrone
Vincristine
L'asparaginase
Cytarabine
Lomustine
24
Q

Which drugs rarely cause GI signs?

A
Vinblastine 
Chlorambucil
Carboplatin
Melphalan
Cyclophosphamide
25
Q

What specific GI problems can be caused by chemo?

A
l-Asparaginase
Haemorrhagic pancreatitis
Vincristine
Paralytic ileus
 Methotrexate
Diarrhoea

• Chronic diarrhoea
Altered intestinal flora
Parasites

26
Q

How do you treat mild GI s/e?

A

• Patient frequently inappettant after treatment
Tempt with high value foods
Consider appetite stimulants
• Patient well but mild / moderate vomiting and or
diarrhoea
Starve for 24 hours
Give oral antiemetics or metronidazole for diarrhoea
• BEWARE patients very prone to dehydration
Intestinal tract is damaged so oral rehydration can be
difficult

27
Q

How do you tx severe GI s/e

A

Admit
CBC and biochemistry to assess clinical status
IV fluids
Assess for pain
Anti-emetic drugs
Antibacterials and GI protectants if haemorrhagic
diarrhoea
Supportive treatment until the patient recovers

28
Q

What can you consider doing if the patient was sick following the last treatment?

A
• Dose reduce
But BEWARE of reduced effect
• Give medications
Prophylactic anti-emetics
• Increase inter treatment interval
For drugs which caused prolonged myelosuppression
• Change drug or protocol
To a potentially less toxic one
• Stop treatment!
29
Q

What are the main drugs that can cause extravasion injury?

A
Vinca alkaloids (Vincristine and vinblastine)
Anthracyclines (Epirubicin, doxyrubicin, actinomycin – D, mitoxantrone)
Cisplatin (now rarely used)
30
Q

How can you treat specific extravasion injuries?

A

Vincristine - will eventually heal

Doxorubicin - need surgical debridement

31
Q

Outline first aid for extravasion injuries

A
  1. Stop treatment
  2. Withdraw any drug through catheter where possible
    • DO NOT TRY TO DILUTE DRUG BY FURTHER FLUSHING
  3. Contact a clinical onc Contact a clinical oncologist for advice for advice.
  4. Advise owner of occurrence

• Consider immediate surgical debridement for
anthracyclines extravasation where feasible.
• Local infiltration of hyaluronidase has been reported to be beneficial.
• For anthracyclines, IV administration of dexrazoxane
(Cardioxam), within 3 hours and again at 24 and 48 hours after extravasation may be beneficial

32
Q

Outline sterile haemorrhagic cystitis d/t cyclophosphamide

A
• Due to acrolein a metabolite of cyclophosphamide irritating the bladder wall.
• Clinical signs vary 
From mild to severe
Persistent and permanent incontinence
Typically dog rather than cats
• Important to rule out other causes of cystitis
Urinary tract infection
Stones
33
Q

How can you manage haemorrhagic sterile cystitis?

A

• Substitute cyclophosphamide for another drug
• Treatment
Analgesia (tramadol, NSAIDs?)
DMSO bladder flushes at weekly intervals
Time
all canine patients receiv-ing cyclophosphamide undergo urine dipstick analysis at least once every two weeks.

Prevention
Monitor for blood in urine pre and post treatment
Increase urine output
Frusemide, IV fluids, encouraging dog to drink, giving plenty of outside access
Mesna (drug)

34
Q

Outline cardiac toxicity

Doxorubicin/ epirubicin

A

• Two forms seen
Acute arrythmia’s due to rapid infusion of drug - Can lead to collapse
Reduced cardiac contraction strength at high cumulative doses
Can lead to DCM and heart failure
• Prevention of acute arrythmia’s
Slow administration of drug
Monitoring pulse and ideally ECG trace
• Cumulative cardiotoxicity
Cumulative doses over 180 - 240 mg/m2
Problems worse if drug given by rapid infusion
• Prevention of cumulative cardiotoxicity
Pre treatment echocardiography
Give drug slowly
If heart problems or high doses use alternate drug
At high doses consider use of dexarozane (Cardiozam ®)

35
Q

Outline hepatotoxicity (lomustine)

A
• A delayed, cumulative dose related hepatic toxicity
This can lead to liver failure
Cause is currently unknown
Can sometimes be an acute problem
• Prevention
Monitor liver enzymes, particularly ALT and bile acids
STOP treatment if ALT is climbing
Do not treat for longer than six months
SAM-e containing drugs
36
Q

Outline renal toxicity

A

• Doxorubicin, epirubicin and lomustine
Can each cause cumulative dose related renal toxicity
Doxorubicin and epirubicin can particularly affect cats
• Cisplatin is very nephrotoxic but rarely used
• Prevention
Important to monitor renal function – BUN, creat, USG
Before and after treatment
Give fluids before and after treatment in cats
STOP treatment if problems

37
Q

Outline neurotoxicity

A

• Vincristine
Occasionally causes peripheral neuropathy in dogs
Leads to hindlimb weakness
Patients usually recover after treatment is stopped
• Cisplatin
Reported to occasionally cause blindness in dogs
• 5-Fluorouracil
Causes neurological signs and death in cats

38
Q

Outline s/e of steroids

A

• Included in many chemotherapy protocols
Often initially at high doses
Owners are often most worried about their side effects
• Side effects
Panting, PU/PD, Polyphagia, Lethargy, GI bleeding
• Prevention / Treatment
Warn owners to expect them
GI protectants to reduce GI bleeding

39
Q

Outline acute tumour lysis syndrome

A

• May occur in patient with large tumour burden
Most frequently in lymphoma patients
Due to rapid destruction of tumour cells
• Clinical signs
Depression, vomiting, diarrhoea, collapse, shock
• Blood tests
Renal failure, hyperkalaemia, hyperphosphataemia,
hypocalcaemia, serum bicarbonate depletion  metabolic acidosis
• Treatment
Fluid therapy
Allopurinol

40
Q

Outline acute tumour lysis syndrome

A

• May occur in patient with large tumour burden
Most frequently in lymphoma patients
Due to rapid destruction of tumour cells
• Clinical signs
Depression, vomiting, diarrhoea, collapse, shock
• Blood tests
Renal failure, hyperkalaemia, hyperphosphataemia,
hypocalcaemia, serum bicarbonate depletion  metabolic acidosis
• Treatment
Fluid therapy
Allopurinol

41
Q

What are the main types of lymphoma?

A

multicentric, alimentary, cutaneous, cranial mediastinal and ‘other’ categories. Approximately 80 per cent of cases of canine lymphomas are categorised as being multi-centric, and approximately 80 per cent of feline lymphomas are of the alimentary type

42
Q

What are the chemotherapy options for lymphoma

A

Administration of prednisolone alone; COP chemotherapy; CHOP chemotherapy.
The COP and the CHOP protocols represent the principal therapeutic strategies used, and the common ground between them is the combination of cyclo-phosphamide (C), vincristine (O) and prednisolone (P). The addition of doxorubicin (H – it is actually hydroxydaunorubicin)

43
Q

Compare COP and CHOP

A

CHOP protocols are superior to the outcomes described for dogs receiving a COP protocol; however, it is also true that there is a higher mortality rate with CHOP protocols. CHOP treatment carries greater risks of moderate to severe gastrointestinal or myelosuppressive side effects than a COP protocol. The inclusion of doxorubicin in the treatment also confers a risk of cardiotoxicity
COP protocols endure for the life of the patient or until progressive disease develops. In contrast, a number of stud-ies demonstrate that comparable outcomes are achieved using long-term (two years plus) and short-term (19 to 28 weeks) CHOP protocols

44
Q

Outline the principle of rescue therapy

A

selection of a treatment based on known (unlikely) or presumed (likely) resistance mechanisms. The most common of these is overexpression of the ABCB1 drug export molecule, previously known as the p-glycoprotein multidrug resistance protein. Agents that are not substrates for the ABCB1 export molecule include cytosine arabinoside, cyclophosphamide, L-asparaginase, lomustine, dacarbazine and temozolomide.

45
Q

What are the grades of mast cells

A

Well-differentiated, with a characteristic ‘benign’ behaviour;
High-grade, with typically aggressive behaviour;
Intermediate-grade, with potentially any clinical behaviour

46
Q

When is chemo appropriate for MCTs?

A

known to be high-grade tumours and those that exhibit regional lymph node, or systemic, metastasis

47
Q

What are the typical protocols for MCT

A

Pred and vinblastine

Lomustine (higher morbidity and mortality rate)

48
Q

What is the prognosis for MCT patients needing chemo

A

Patients with metastatic intermediate-grade mast cell tumours that achieve complete remission can be expected to remain in this state for six to 18 months. Metastatic high-grade tumours rarely enter complete remission in response to chemotherapy alone, and such patients would not be expected to live more than six months from the time of diagnosis.

49
Q

What is used in osteosarcoma chemotherapy?

A

Carboplatin

50
Q

What is the aim of metronomic chemo?

A

Rather than targeting the rapidly dividing tumor cell population, metronomic chemotherapy slows or stops tumor growth by inhibiting tumor angiogenesis and evasion from the immune system.
May also be immunostimulatory to reduce the immunosuppression that tumours can induce

51
Q

What may work synergistically with metronomic chemotherapy?

A

other antiangiogenic agents such as cyclooxygenase (COX)-2 and receptor tyrosine kinase inhibitors is an area of active investigation.